NAC treatment decreases cytokine signaling in <i>Ptpn11</i> GOF mutant cells. by Dan Xu (138152)

H₂S is responsible for decreased active MMP-1/TIMP-1 ratio. by Ingrid Gomez (520676)

Decreased levels of PRMT1 alters BRCA1 promoter binding <i>in vivo.</i> by Irene Guendel (173419)

H₂S is responsible for decreased active MMP-1/TIMP-2 ratio. by Ingrid Gomez (520676)

Positive modulation of mGluR5 decreases spine density in the nucleus accumbens but not in the dorsal striatum. by Kellie S. Gross (3115299)

“…<p>(A) Twenty-four hours after systemic administration, CDPPB (5–10 mg/kg, <i>n</i> = 18 animals) decreased dendritic spine density and frequency of small head diameter spines (0.2 μm bin) compared to vehicle control (<i>n</i> = 8) in the nucleus accumbens core. …”

SHIP-1 decreases NOD2-induced NF-κB activation in epithelial cells. by Claude Condé (150801)

Belinostat decreases both male and female bladder weights in transgenic superficial bladder cancer mice by Michael T Buckley (37161)

“…Normal non-transgenic mouse bladders weigh approximately 10.0 mg at the same age, and Ha-transgenic mice with superficial bladder cancer have a 3 fold and higher bladder weight. , Male belinostat-treated mice (n = 4, 327.5 mg average weight) showed a two-fold decrease (50%, p = 0.03) in bladder weight versus control (n = 4, 652.5 mg average weight). , Female belinostat-treated mice (n = 5, 34.0 mg average weight) showed a 36% decrease (p = 0.04) in bladder weight versus control (n = 6, 53.3 mg average weight).…”

DJ-1 gene deletion decreases mitochondrial respiratory chain function in dopaminergic neuronal cells. by Jun Young Heo (179572)

Heteroplasmy evolution of cybrid clone V_50. by Anton K. Raap (109844)

“…<p>(A) Average cellular mutation load decreases with increasing passage number of clone V_50. …”

Methylation levels of the <i>Ucp1</i> promoter decreased following genistein (GEN) treatment. by Noriko Sato (201880)

Sustained expression of radmis results in decreased cell proliferation and increased cell-cycle exit of NSPCs. by Takahito Yumoto (481671)

Inhibitor treatment decreases capsule production in different pathogenic <i>E. coli</i> serotypes. by Carlos C. Goller (245570)

Neutrophil activation and recruitment and CXCR2 expression were decreased in antibiotic pre-treated mice. by Koji Watanabe (205444)

Incubation of V79-CYP3A94/DD-POR cells with Shield-1 leads to a decrease of POR protein. by Ramona Dettwiler (664360)

Evaluation of glucose consumption and lactate production in culture medium of HL-1 cells exposed to LG, NG, HG and IHG during 12 and 72h. by Patrick Mordel (17020879)

B-RAF inhibitor PLX4720 decreased hERG currents in rhabdomyosarcoma RD cells. by Tatsiana Pakladok (311653)

Quantitative RT-qPCR demonstrate that Tat complex modulates expression of C5, CRLF2, APBA1, and BDNF. by Loreto Carvallo (4167607)

“…Tat complex increased the expression of C5 at 24 and 48 hours, decreased the expression of CRLF2 at 24 and 48 hours, increased the expression of APBA1 at 48 hours and increased the expression of BDNF after 24 hours of PMA treatment. …”

TSA decreases the abundance of BrUdR labeled nascent strands at primary initiation sites by Michael G. Kemp (6695)

Basal ubiquitination of GlyT2 in neurons decreases when the pool of free monomeric ubiquitin is reduced. by Jaime de Juan-Sanz (386083)

HAART does not affect CTLA-4 expression, but significantly decreases CD39 expression in Tregs. by Pietro Presicce (144163)